HIV/AIDS
The latest HIV/AIDS news from UNC Health Care and the UNC School of Medicine.
Innate immune system can kill HIV when a viral gene is deactivated
Study published in PLoS Pathogens suggests new target for treatment and the eventual cure of HIV/AIDS
Wake County HIV Clinic Recognized as Statewide Leader in HIV Care
UNC faculty members Robert Dodge, PhD, RN, ANP, Jacqueline Gibson, PA-C, Victoria Mobley, MD, Esther Metiko, FNP and Ann Dennis, MD, work at the Raleigh-based clinic, which has over 900 patients.
White House U.S. National HIV/AIDS Implementation Meeting
The Institute for Global Health & Infectious Diseases is co-hosting a delegation from the White House Office of National AIDS Policy, including ONAP director Grant Colfax. Part of their visit will involve a U.S. National HIV/AIDS Implementation Meeting in Chapel Hill on February 21, 2013.
Cohen named "Tar Heel of the Year" by the Raleigh News & Observer
Myron Cohen, MD, J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, was featured in the Sunday, Dec. 30 issue of the N&O along with Robert J. Lefkowitz, MD, also a "Tar Heel of Year" for 2012.
UNC-led consortium awarded $4 million to train next generation of global health researchers
The consortium, which involves four partnering institutions, will support early-career scientists and clinicians during a yearlong research fellowship at 17 sites in 13 countries in Africa, Asia, and South America.
UNC’s Myron Cohen and Terry Magnuson elected to Institute of Medicine
Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
ID Conference: “Lessons from Botswana: Prevention and Treatment in the World’s Worst Epidemic of HIV/AIDS”
The presenter is Max Essex, DVM, PhD, Lasker Professor of Health Sciences at Harvard University, Chair of the Harvard School of Public Health AIDS Initiative, and Chair of the Botswana–Harvard AIDS Institute in Gaborone, Botswana.
UNC-led team awarded $2 million supplemental grant to support AIDS cure research
The Collaboratory of AIDS Researchers for Eradication, or CARE, a multi-institutional research team led by David Margolis, MD, professor of medicine at the UNC School of Medicine, has been awarded a $2 million supplemental grant from the National Institutes of Health to conduct expanded analysis of resting CD4+ T-cells of people infected with HIV.
Pioneering study shows drug can purge dormant HIV
Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment for HIV.
UNC research to be featured at world’s largest AIDS conference
Research from every corner of the UNC campus will be represented at the International AIDS Conference, to be held July 22-27 in Washington, D.C.
Cohen co-authors "Pre-exposure Prophylaxis for HIV - Where Do We Go from Here?" in the New England Journal of Medicine
Myron Cohen, MD, collaborated with Lindsay Bahen, MD, from Brigham and Women's Hospital in Boston, Mass., for this editorial that was published in the New England Journal of Medicine.
Breast milk kills HIV and blocks its oral transmission in humanized mouse
New research from the University of North Carolina School of Medicine demonstrates that breast milk in a humanized mouse model has a strong virus killing effect and protects against oral transmission of HIV.
Immune cells in the gut may improve control of HIV growth
A new study may help clarify why some people infected with HIV are better able to control the virus. It may also pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut.
HIV hides soon after infection, UNC research shows
A team of researchers led by the University of North Carolina School of Medicine has demonstrated that latency develops soon after infection and slows when antiretroviral therapy is given.
Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies
New research finds that early weaning – stopping breastfeeding before six months – is of little, if any, protective value against HIV transmission nor is it safe for infant survival.
UNC professor Myron Cohen wins top award from Clinical Research Forum for HIV prevention study
Cohen’s study, HIV Prevention Trials Network 052, showed that treating people with HIV with antiretroviral therapy renders them virtually non-contagious, reducing sexual transmission by 96 percent.
Cohen profiled by Science magazine
Learn more about the HPTN study, called the "Breakthrough of the Year," in this Q&A about the the process of discovery with Dr. Mike Cohen, Director of the UNC Institute for Global Health and Infectious Diseases.
Triangle Business Journal names Cohen, Zanation, Sharpless "Health Care Heroes"
Dr. Myron Cohen won the Lifetime Achievement Award, Dr. Norman Sharpless, the Innovator/Researcher award, and Dr. Adam Zanation the "Rising Star" award.
Hematologic malignancies rapidly increasing and unaddressed in sub-Saharan Africa
UNC-led team offers clinical, research agenda
Drug helps purge hidden HIV virus, study shows
This study is the first to demonstrate that the biological mechanism that keeps the HIV virus hidden and unreachable by current antiviral therapies can be targeted and interrupted in humans, providing new hope for a strategy to eradicate HIV completely.
